BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totaling 8,126 shares, a growth of 156.0% from the June 15th total of 3,174 shares. Based on an average trading volume of 16,334 shares, the short-interest ratio is currently 0.5 days.
BioSyent Price Performance
Shares of BIOYF stock opened at $10.29 on Tuesday. BioSyent has a 1 year low of $7.63 and a 1 year high of $12.00. The firm has a fifty day moving average price of $10.17 and a 200-day moving average price of $10.31.
BioSyent Company Profile
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Featured Stories
- Five stocks we like better than BioSyent
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
